878119P

C16 Lyso PAF

Avanti Research^™ - A Croda Brand 878119P, powder

• Synonym(e): 1-O-hexadecyl-2-hydroxy-sn-glycero-3-phosphocholine
• Empirische Formel (Hill-System): C₂₄H₅₂NO₆P
• CAS-Nummer: 52691-62-0
• Molekulargewicht: 481.65
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 5 mg (878119P-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 878119P
• Lipid-Typ: bioactive lipids; phosphoglycerides
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COCCCCCCCCCCCCCCCC
• InChI: 1S/C24H52NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-29-22-24(26)23-31-32(27,28)30-21-19-25(2,3)4/h24,26H,5-23H2,1-4H3/t24-/m1/s1
• InChIKey: VLBPIWYTPAXCFJ-XMMPIXPASA-N

Beschreibung

Anwendung

C16 Lyso PAF is suitable for the use in thin layer chromatography for the synthesis of acyl-platelet activating factor (PAF). It is also suitable for intraperitoneal injection into mice to compare the relative inhibitory actions of acyl-PAF, lyso-PC and lyso-PAF on alkyl PAF-induced death.

Verpackung

5 mL Amber Glass Screw Cap Vial (878119P-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable